Atlas Capital Advisors’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2K Buy
+244
New +$14.1K ﹤0.01% 882
2024
Q2
Sell
-97
Closed -$16.7K 904
2024
Q1
$16.7K Buy
+97
New +$14.8K ﹤0.01% 679
2022
Q3
Sell
-6
Closed -$705 928
2022
Q2
$705 Hold
6
﹤0.01% 941
2022
Q1
$857 Sell
6
-90
-94% -$13.7K ﹤0.01% 869
2021
Q4
$16.1K Hold
96
﹤0.01% 661
2021
Q3
$14.5K Hold
96
﹤0.01% 674
2021
Q2
$14.6K Sell
96
-57
-37% -$9.05K ﹤0.01% 688
2021
Q1
$22.9K Hold
153
﹤0.01% 583
2020
Q4
$19.9K Buy
+153
New +$19K ﹤0.01% 546
2020
Q2
Sell
-126
Closed -$9.25K 676
2020
Q1
$9.25K Sell
126
-1,766
-93% -$175K ﹤0.01% 587
2019
Q4
$233K Buy
+1,892
New +$233K 0.06% 298

Other funds holding CE

Atlas Capital Advisors's CE Position: Q2 2026 in Review

Atlas Capital Advisors opened a new position in Celanese (CE) in Q2 2026: 244 shares worth $11.2K. The stake represents ﹤0.01% of the portfolio and ranks #882 among its holdings. This is a return to the name: Atlas Capital Advisors previously reported a position in CE as recently as Q1 2024.

Atlas Capital Advisors first reported a position in CE in Q4 2019 and has held it in 11 quarters since. The position peaked at $233K in Q4 2019. 460 funds tracked by Wall St. Rank hold CE as of Q2 2026.

  • Atlas Capital Advisors held 244 shares of Celanese worth $11.2K as of Q2 2026.
  • Celanese was a new Atlas Capital Advisors position in Q2 2026.
  • Celanese made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #882 holding.
  • Atlas Capital Advisors first reported a position in Celanese in Q4 2019 and has held it in 11 quarters since.
  • Atlas Capital Advisors's Celanese position peaked at $233K in Q4 2019.
  • 460 funds tracked by Wall St. Rank held Celanese as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.